Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global HIV control: is the glass half empty or half full?
Nachega JB, Musoke P, Kilmarx PH, Gandhi M, Grinsztejn B, Pozniak A, Rawat A, Wilson L, Mills EJ, Altice FL, Mellors JW, Quinn TC. Nachega JB, et al. Among authors: pozniak a. Lancet HIV. 2023 Sep;10(9):e617-e622. doi: 10.1016/S2352-3018(23)00150-9. Epub 2023 Jul 25. Lancet HIV. 2023. PMID: 37506723 Free PMC article. Review.
The global burden of HIV.
Payagala S, Pozniak A. Payagala S, et al. Among authors: pozniak a. Clin Dermatol. 2024 Mar-Apr;42(2):119-127. doi: 10.1016/j.clindermatol.2024.02.001. Epub 2024 Feb 21. Clin Dermatol. 2024. PMID: 38387533
Reply to 'Cognitive criteria in HIV: greater consensus is needed'.
Nightingale S, Cinque P, Dravid A, Dreyer AJ, Gisslén M, Joska JA, Kwasa J, Meyer AC, Mpongo N, Nakasujja N, Pebody R, Pozniak A, Price RW, Saylor D, Thomas KGF, Underwood J, Vera JH, Winston A. Nightingale S, et al. Among authors: pozniak a. Nat Rev Neurol. 2024 Feb;20(2):129-130. doi: 10.1038/s41582-024-00928-0. Nat Rev Neurol. 2024. PMID: 38228907 No abstract available.
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa.
Katongole F, Arumugam T, Jennings A, Mutata C, Ssebunya P, Wamboi C, Green A, Bwakura-Dangarembizi M, Kityo C, Siika A, Archary M, Jafta L, Namukwaya S, Seeley J, Mugerwa H, Walker S, Apoto N, Thomason MJ, Ford D, Pett SL, Kekitiinwa AR; BREATHER Plus trial team. Katongole F, et al. Contemp Clin Trials. 2025 May 29;155:107963. doi: 10.1016/j.cct.2025.107963. Online ahead of print. Contemp Clin Trials. 2025. PMID: 40449658 Free article.
Use of doravirine-based regimens in clinical practice in Europe.
Rami A, Pozniak AL, Assoumou L, Movahedi R, Lacombe K, Raffi F, Fox J, Levi L, Melnyk T, Roberts D, Fletcher C, Molina JM; DREW Study Group. Rami A, et al. Among authors: pozniak al. AIDS. 2025 Jul 1;39(8):975-985. doi: 10.1097/QAD.0000000000004151. Epub 2025 Feb 12. AIDS. 2025. PMID: 39945634
564 results